HOME
PeptAid
Glioblastoma is the most aggressive and incurable brain tumor, and we’re pioneering development of immunotherapeutic peptides to improve patient outcomes.
Our technology
The proposed solution, a synthetic blocking peptide, offers a disruptive therapeutic concept targeting tumor - host interactions. This approach features a novel mechanism of action, low toxicity, and strong potential for synergy with existing and emerging treatments, anticipating prolonged patient survival and improved quality of life.
WHO WE ARE?